monocrotaline and Atrial Fibrillation

monocrotaline has been researched along with Atrial Fibrillation in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's4 (100.00)2.80

Authors

AuthorsStudies
de Lima Conceição, MR; Leal-Silva, P; Roman-Campos, D; Teixeira-Fonseca, JL1
Balakin, AA; Gerzen, OP; Kuznetsov, DA; Lisin, RV; Mukhlynina, EA; Nikitina, LV; Protsenko, YL1
Beserra, SS; de Lima Conceição, MR; Joviano-Santos, JV; Leal-Silva, P; Marques, LP; Roman-Campos, D; Souza, DS; Teixeira-Fonseca, JL1
Bo, Y; Cui, Z; Tianxin, Y; Weiguo, W; Yi, Y; Zhangchi, L1

Other Studies

4 other study(ies) available for monocrotaline and Atrial Fibrillation

ArticleYear
Ranolazine exerts atrial antiarrhythmic effects in a rat model of monocrotaline-induced pulmonary hypertension.
    Basic & clinical pharmacology & toxicology, 2023, Volume: 132, Issue:5

    Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease Models, Animal; Heart Atria; Hypertension, Pulmonary; Monocrotaline; Ranolazine; Rats; Rats, Wistar

2023
Characteristics of the right atrial and right ventricular contractility in a model of monocrotaline-induced pulmonary arterial hypertension.
    Journal of muscle research and cell motility, 2023, Volume: 44, Issue:4

    Topics: Animals; Atrial Fibrillation; Disease Models, Animal; Heart Atria; Heart Ventricles; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Monocrotaline; Pulmonary Arterial Hypertension; Rats

2023
Exploring the involvement of TASK-1 in the control of isolated rat right atrium function from healthy animals and an experimental model of monocrotaline-induced pulmonary hypertension.
    Naunyn-Schmiedeberg's archives of pharmacology, 2023, Volume: 396, Issue:12

    Topics: Animals; Atrial Fibrillation; Heart Atria; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Models, Theoretical; Monocrotaline; Rats; Rats, Wistar

2023
Pinocembrin attenuates susceptibility to atrial fibrillation in rats with pulmonary arterial hypertension.
    European journal of pharmacology, 2023, Dec-05, Volume: 960

    Topics: Animals; Atrial Fibrillation; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Fibrosis; Monocrotaline; Pulmonary Arterial Hypertension; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Vascular Remodeling

2023